Generic drugs market to hit $681.4 billion by 2034

The item does not contain any market projections, financial figures, or growth rates.
AccessibleMeds stated that savings from generic and biosimilar medicines bring patients relief from prescription costs and add value state by state.
This report highlights projected growth in generic medicines and ongoing state-by-state prescription cost relief for consumers.
News cardSave this story as an image, or share it






